Diabetes drug trial aims to shrink dangerous liver fat
NCT ID NCT02721888
Summary
This study tested if liraglutide, a medication for type 2 diabetes, could reduce fat buildup in the liver and improve cholesterol levels. It involved 127 adults with type 2 diabetes who took the drug for six months. Researchers used special scans and blood tests to measure changes in liver fat and cholesterol production.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Dijon
Dijon, 21079, France
Conditions
Explore the condition pages connected to this study.